Actively Recruiting

Age: 18Years - 60Years
All Genders
NCT06650826

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

Led by Cardioangiologisches Centrum Bethanien · Updated on 2024-10-21

200

Participants Needed

2

Research Sites

130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Prospective investigation of the incidence of anti-platelet factor 4 antibodies in suspected immune-associated arterial and/or venous thrombosis

CONDITIONS

Official Title

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18-60 years
  • Written informed consent of the patient
  • Spontaneous arterial and/or venous thrombosis
  • Infection-associated arterial and/or venous thrombosis within 30 days of infection
  • Vaccine-associated arterial and/or venous thrombosis within 30 days of vaccination
  • Recurrent arterial or venous thrombosis despite anticoagulant therapy
Not Eligible

You will not qualify if you...

  • Lack of consent of the patient
  • Risk-associated venous thromboses such as following surgery, immobilization, plaster cast, fractures, or sprains
  • Risk-associated arterial thromboses in the presence of vascular risk factors such as diabetes mellitus, hypercholesterolemia, hypertension, or nicotine abuse
  • Thromboses more than 120 days old at the time of blood sampling

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Deutsches Herzzentrum der Charite (DHZC)

Berlin, Germany, 10117

Not Yet Recruiting

2

Cardioangiologisches Zentrum Bethanien (CCB)

Frankfurt am Main, Germany, 60389

Actively Recruiting

Loading map...

Research Team

E

Edelgard Lindhoff-Last, Professor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis | DecenTrialz